49. Systemic lupus erythematosus Clinical trials / Disease details


Clinical trials : 993 Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03626311
(ClinicalTrials.gov)
October 23, 20186/6/2018Omega-3 Replacement With Krill Oil in Disease Management of SLEA Double-Blind, Placebo-Controlled Randomized, Multicenter Study to Assess Changes in Omega-3 Index in Erythrocytes and Health Benefit After 24 Weeks of Daily Consumption of AKBM-3031 (Omega-3 Phospholipids From Krill), Followed by a 24 Week Open-Label Extension, in Patients With Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosus (SLE)Dietary Supplement: AKBM-3031;Other: PlaceboAker Biomarine Antarctic ASAmpel BioSolutions, LLCCompleted18 YearsN/AAll76N/AUnited States;Canada
2NCT02021513
(ClinicalTrials.gov)
January 201213/12/2013Pilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusPilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusSystemic Lupus ErythematosusDietary Supplement: Fish Oil;Dietary Supplement: Olive OilUniversity of Texas Southwestern Medical CenterNULLCompleted18 Years64 YearsBoth50Phase 2United States
3NCT02524795
(ClinicalTrials.gov)
March 20098/7/2015Omega 3 Fatty Acids and Systemic Lupus ErythematosusOmega 3 Fatty Acids, Inflammatory Status and Biochemical Markers of Patients With Systemic Lupus Erythematosus: a Pilot StudySystemic Lupus ErythematosusDietary Supplement: Hiomega-3 supplement of Naturalis® company -Federal University of Minas GeraisNULLCompleted18 Years60 YearsFemale49N/ANULL
4NCT00828178
(ClinicalTrials.gov)
February 200922/1/2009Efficacy of Fish Oil in Lupus PatientsA Randomized, Double-blind, Placebo-controlled, Clinical Trial of Omega-3-polyunsaturated Fatty Acids in Subjects With SLE.Systemic Lupus ErythematosusDrug: Omega-3;Device: flow-mediated dilation of the brachial artery;Other: corn starchMichelle Petri M.D.,MPHNULLCompleted18 YearsN/AAll106Phase 4United States
5EUCTR2004-004404-21-GB
(EUCTR)
10/12/200417/02/2005Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences - Fish oils in LupusOmega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences - Fish oils in Lupus Systemic Lupus ErythematosusTrade Name: Omacor
Product Name: Omacor
INN or Proposed INN: Eicosapentaenoic acid
INN or Proposed INN: Docosahexaenoic acid
INN or Proposed INN: alpha-tocopherol
GreenPark Healthcare TrustQueens University BelfastNot RecruitingFemale: yes
Male: yes
60Phase 4United Kingdom